- Home
- OZ vs OCGN Comparison
OZ vs OCGN Comparison
Compare OZ & OCGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OZ
- OCGN
- Stock Information
- Founded
- OZ 2020
- OCGN 2013
- Country
- OZ United States
- OCGN United States
- Employees
- OZ N/A
- OCGN N/A
- Industry
- OZ
- OCGN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- OZ
- OCGN Health Care
- Exchange
- OZ Nasdaq
- OCGN Nasdaq
- Market Cap
- OZ 237.6M
- OCGN 283.3M
- IPO Year
- OZ N/A
- OCGN N/A
- Fundamental
- Price
- OZ $63.88
- OCGN $1.01
- Analyst Decision
- OZ
- OCGN Strong Buy
- Analyst Count
- OZ 0
- OCGN 3
- Target Price
- OZ N/A
- OCGN $6.00
- AVG Volume (30 Days)
- OZ 2.1K
- OCGN 3.6M
- Earning Date
- OZ 01-01-0001
- OCGN 08-01-2025
- Dividend Yield
- OZ N/A
- OCGN N/A
- EPS Growth
- OZ N/A
- OCGN N/A
- EPS
- OZ N/A
- OCGN N/A
- Revenue
- OZ $4,077,000.00
- OCGN $4,754,000.00
- Revenue This Year
- OZ N/A
- OCGN N/A
- Revenue Next Year
- OZ N/A
- OCGN N/A
- P/E Ratio
- OZ N/A
- OCGN N/A
- Revenue Growth
- OZ 94.70
- OCGN N/A
- 52 Week Low
- OZ $56.77
- OCGN $0.52
- 52 Week High
- OZ $82.89
- OCGN $1.40
- Technical
- Relative Strength Index (RSI)
- OZ 39.75
- OCGN 45.53
- Support Level
- OZ $65.25
- OCGN $1.01
- Resistance Level
- OZ $65.87
- OCGN $1.11
- Average True Range (ATR)
- OZ 0.45
- OCGN 0.07
- MACD
- OZ -0.22
- OCGN -0.01
- Stochastic Oscillator
- OZ 0.00
- OCGN 21.52
About OZ Belpointe PREP LLC Units
Belpointe PREP LLC is a qualified opportunity fund. The company's investments consist of properties located in qualified opportunity zones for the development or redevelopment of multifamily, student housing, senior living, healthcare, industrial, self-storage, hospitality, office, mixed-use, data centers, and solar projects located throughout the United States and its territories. Company currently has two reporting segments, commercial: includes properties such as office, retail centers, and warehouses; and mixed-use: includes properties that blend both residential and retail components within a single real estate asset.
About OCGN Ocugen Inc.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").